Back

Nanobodies as novel potential drugs to target cardiac light chain amyloidosis

30 April 2022 (08:30 - 17:00)
Organised by: Logo
Congress Presentation Part of: Poster Session 2 Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Mr Luca Broggini

IRCCS San Donato Polyclinic, San Donato Milanese (Italy)

69 More presentations in this session

Presentation thumbnail
Evidence of Sialylation pathways alteration in peripheral blood of Brugada Syndrome patients
Mrs A. Tarantino (Milan, IT)
Abstract
Presentation thumbnail
Autopsy and genetic characterization of juvenile sudden cardiac arrest and death: the ToRSADE experience
Doctor V. Spinelli (Florence, IT)
Abstract
Presentation thumbnail
Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy
Miss N. Kaur (Manchester, GB)
Abstract
Presentation thumbnail
Immunomodulatory effect of different statin regimens on regulatory T-cells among patients with acute coronary syndrome: a systematic review and network meta-analysis of randomized clinical trials
Doctor E. Greca (Miami, US)
Abstract
Presentation thumbnail
Dissection of the role of microRNAs in cardiac fibrosis through functional genomics screenings
Doctor M. Mano (Coimbra, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms
29 August 2022
thumbnail
Congress Presentation
Characterization of AT-02, a pan-amyloid-binding peptide fusion immunoglobulin with high binding potency, complement activation, and immune cell stimulation
27 August 2023
thumbnail
Congress Presentation
Mortality & inpatient hospitalizations amongst patients with cardiac light-chain amyloidosis: results from a US administrative claims database
20 June 2025
thumbnail
Congress Presentation
Low-dose cardiac radiotherapy effect in TTR cardiac amyloidosis
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources